Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN)

CUSIP: 23954D109

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
101,960,784
Total 13F shares
72,782,347
Share change
-3,783,489
Total reported value
$1,202,300,406
Put/Call ratio
129%
Price per share
$16.52
Number of holders
147
Value change
-$58,498,635
Number of buys
73
Number of sells
59

Quarterly Holders Quick Answers

What is CUSIP 23954D109?
CUSIP 23954D109 identifies DAWN - Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) as of Q1 2024

As of 31 Mar 2024, Day One Biopharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (DAWN) was held by 147 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 72,782,347 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Atlas Venture Life Science Advisors, LLC, BlackRock Inc., VANGUARD GROUP INC, FMR LLC, FRANKLIN RESOURCES INC, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, PICTET ASSET MANAGEMENT Holding SA, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 147 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.